Literature DB >> 25713334

Urinary biomarkers of catechins and risk of hepatocellular carcinoma in the Shanghai Cohort Study.

Lesley M Butler, Joyce Yongxu Huang, Renwei Wang, Mao-Jun Lee, Chung S Yang, Yu-Tang Gao, Jian-Min Yuan.   

Abstract

Dietary catechins are phytochemicals with both antioxidative and prooxidative stress properties. Green tea is a major source of catechins and may be associated with hepatocellular carcinoma (HCC) risk, but the catechin-HCC relationship has not been evaluated using a biomarker-based approach. A nested case-control study of HCC (211 cases and 1,067 matched controls) was conducted within the Shanghai Cohort Study, which enrolled 18,244 men between 1986 and 1989. Concentrations of specific catechins, including epicatechin, epigallocatechin (EGC), and 4'-O-methyl-epigallocatechin, were measured in urine specimens that had been collected prior to HCC diagnosis. None of the catechins measured were associated with HCC risk. In stratified analyses, there was a statistically significant trend for an association of higher urinary EGC with increased HCC risk among subjects with positive serology for hepatitis B surface antigen (P for trend = 0.02). This positive EGC-HCC association became stronger for hepatitis B surface antigen-positive persons who also had low serum retinol levels (for detectable levels vs. undetectable levels, odds ratio = 2.62, 95% confidence interval: 1.25, 5.51). There was no evidence supporting a protective role of catechins in the development of HCC. Instead, exposure to high levels of catechins may increase the risk of developing HCC for high-risk individuals.
© The Author 2015. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  catechins; flavonoids; green tea; hepatocellular carcinoma; retinol

Mesh:

Substances:

Year:  2015        PMID: 25713334      PMCID: PMC4380019          DOI: 10.1093/aje/kwu304

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  49 in total

Review 1.  Hepatocellular carcinoma.

Authors:  Hashem B El-Serag
Journal:  N Engl J Med       Date:  2011-09-22       Impact factor: 91.245

2.  Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice.

Authors:  Joshua D Lambert; Mary J Kennett; Shengmin Sang; Kenneth R Reuhl; Jihyeung Ju; Chung S Yang
Journal:  Food Chem Toxicol       Date:  2009-10-31       Impact factor: 6.023

Review 3.  The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention.

Authors:  Sarah C Forester; Joshua D Lambert
Journal:  Mol Nutr Food Res       Date:  2011-05-02       Impact factor: 5.914

4.  Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro.

Authors:  Guang-Xun Li; Yu-Kuo Chen; Zhe Hou; Hang Xiao; Huanyu Jin; Gary Lu; Mao-Jung Lee; Ba Liu; Fei Guan; Zhihong Yang; Albert Yu; Chung S Yang
Journal:  Carcinogenesis       Date:  2010-02-16       Impact factor: 4.944

5.  Epidemiological studies of the association between tea drinking and primary liver cancer: a meta-analysis.

Authors:  Mélanie Fon Sing; Wan-Shui Yang; Shan Gao; Jing Gao; Yong-Bing Xiang
Journal:  Eur J Cancer Prev       Date:  2011-05       Impact factor: 2.497

6.  Phenol-Explorer: an online comprehensive database on polyphenol contents in foods.

Authors:  V Neveu; J Perez-Jiménez; F Vos; V Crespy; L du Chaffaut; L Mennen; C Knox; R Eisner; J Cruz; D Wishart; A Scalbert
Journal:  Database (Oxford)       Date:  2010-01-08       Impact factor: 3.451

7.  Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.

Authors:  Gary L Davis; Miriam J Alter; Hashem El-Serag; Thierry Poynard; Linda W Jennings
Journal:  Gastroenterology       Date:  2009-10-25       Impact factor: 22.682

8.  Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.

Authors:  Sean F Altekruse; S Jane Henley; James E Cucinelli; Katherine A McGlynn
Journal:  Am J Gastroenterol       Date:  2014-02-11       Impact factor: 10.864

Review 9.  Cancer prevention by tea: animal studies, molecular mechanisms and human relevance.

Authors:  Chung S Yang; Xin Wang; Gang Lu; Sonia C Picinich
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

10.  Epicatechin induces NF-kappaB, activator protein-1 (AP-1) and nuclear transcription factor erythroid 2p45-related factor-2 (Nrf2) via phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) and extracellular regulated kinase (ERK) signalling in HepG2 cells.

Authors:  Ana Belén Granado-Serrano; María Angeles Martín; Guy Haegeman; Luis Goya; Laura Bravo; Sonia Ramos
Journal:  Br J Nutr       Date:  2010-01       Impact factor: 3.718

View more
  7 in total

1.  Green tea and liver cancer.

Authors:  Francesca Bravi; Carlo La Vecchia; Federica Turati
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

2.  Prediagnostic levels of urinary 8-epi-prostaglandin F2α and prostaglandin E2 metabolite, biomarkers of oxidative damage and inflammation, and risk of hepatocellular carcinoma.

Authors:  Jian-Min Yuan; Menno Grouls; Steven G Carmella; Renwei Wang; Alisa Heskin; Yang Jiang; Yu-Ting Tan; Jennifer Adams-Haduch; Yu-Tang Gao; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2019-08-22       Impact factor: 4.944

Review 3.  Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma.

Authors:  Tracey G Simon; Andrew T Chan
Journal:  Clin Liver Dis       Date:  2020-08-25       Impact factor: 6.126

4.  Flavan-3-ols consumption and cancer risk: A meta-analysis of epidemiologic studies.

Authors:  Lei Lei; Ying Yang; Hongjuan He; Erfei Chen; Le Du; Jing Dong; Jin Yang
Journal:  Oncotarget       Date:  2016-11-08

Review 5.  Antioxidants in Hops: Bioavailability, Health Effects and Perspectives for New Products.

Authors:  Corina-Aurelia Zugravu; Roxana-Elena Bohiltea; Teodor Salmen; Elena Pogurschi; Marina Ruxandra Otelea
Journal:  Antioxidants (Basel)       Date:  2022-01-27

6.  Effect of Green Tea Supplements on Liver Enzyme Elevation: Results from a Randomized Intervention Study in the United States.

Authors:  Zheming Yu; Hamed Samavat; Allison M Dostal; Renwei Wang; Carolyn J Torkelson; Chung S Yang; Lesley M Butler; Thomas W Kensler; Anna H Wu; Mindy S Kurzer; Jian-Min Yuan
Journal:  Cancer Prev Res (Phila)       Date:  2017-08-01

7.  Green tea (Camellia sinensis) for the prevention of cancer.

Authors:  Tommaso Filippini; Marcella Malavolti; Francesca Borrelli; Angelo A Izzo; Susan J Fairweather-Tait; Markus Horneber; Marco Vinceti
Journal:  Cochrane Database Syst Rev       Date:  2020-03-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.